Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,000)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07212491 | Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma | enrolling by invitation | — | 450 | Mayo ClinicOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT07328516 | Natural History Study of Early Life Exposures in Agriculture (ELEA) | enrolling by invitation | — | 64,277 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2026 |
| NCT00068003 | Harvesting Cells for Experimental Cancer Treatments | enrolling by invitation | — | 7,000 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT06936527 | XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation(XS-03-II201) | enrolling by invitation | Phase 1 / Phase 2 | 102 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07344220 | Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate(DZ-002-201) | enrolling by invitation | Phase 2 | 39 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT04291755 | Development and Analysis of a Stool Bank for Cancer Patients | enrolling by invitation | — | 100 | Persephone BiosciencesINDUSTRY | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07775209 | Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma(SSIBLING) | enrolling by invitation | Phase 2 | 24 | University of Vermont Medical CenterOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07642401 | Large-scale Models of Esophageal Cancer and Related Research(DeepDT) | enrolling by invitation | — | 12,000 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07620574 | Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study | enrolling by invitation | Phase 3 | 5,000 | ExelixisINDUSTRY | 1 | Aug 18, 2026 | clinicaltrials |
| NCT05600933 | Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment | enrolling by invitation | — | 1,200 | National Cancer Institute (NCI)NIH | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06157671 | The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma | enrolling by invitation | — | 1,000 | Adenocyte, LLCINDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06276764 | The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) | enrolling by invitation | — | 500 | Adenocyte, LLCINDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06458998 | Getting To Implementation: Improving Cancer Screening for Veterans(GTI) | enrolling by invitation | N/A | 30,300 | University of PittsburghOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT07708012 | Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric Cancer | enrolling by invitation | N/A | 30 | wangdongshengOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07703735 | Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma(HCC) | enrolling by invitation | — | 371 | Seoung Hoon KimOTHER_GOV | 0 | Jul 14, 2026 | clinicaltrials |
| NCT07697170 | Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi(ICO-MARSI) | enrolling by invitation | N/A | 150 | Institut Català d'OncologiaOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06769087 | Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery(POUR) | enrolling by invitation | N/A | 316 | Seoul St. Mary's HospitalOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT07683195 | Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction(LAGC) | enrolling by invitation | — | 900 | Liu YangOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT07686133 | Digital Education in Colorectal Cancer Patients(GUIDE) | enrolling by invitation | N/A | 100 | University Health Network, TorontoOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT07683949 | Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine(LENCAP-CRC) | enrolling by invitation | Phase 1 / Phase 2 | 93 | Seoul National University Bundang HospitalOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07139951 | Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence | enrolling by invitation | Phase 2 | 16 | Mayo ClinicOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT02427269 | University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository(BEECAB) | enrolling by invitation | — | 1,000 | University of North Carolina, Chapel HillOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT06583564 | The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer | enrolling by invitation | N/A | 192 | Shanghai Tong Ren HospitalOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT02600949 | Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer | enrolling by invitation | Phase 1 | 300 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT07198945 | Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection(STARLING) | enrolling by invitation | N/A | 546 | Indiana UniversityOTHER | 3 | Jun 17, 2026 | clinicaltrials |
| NCT07218003 | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 | enrolling by invitation | Phase 1 | 149 | Rondo TherapeuticsINDUSTRY | 1 | Jun 11, 2026 | clinicaltrials |
| NCT06744595 | Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer | enrolling by invitation | N/A | 50 | Mayo ClinicOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT07621757 | The Implementation of Genetic Risk for Colorectal Cancer Screening(PRO-GENE-COLON) | enrolling by invitation | — | 100 | Endeavor HealthOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06437288 | Hematoporphyrin Photodynamic Therapy for Esophageal Cancer | enrolling by invitation | Phase 4 | 198 | Sun Yat-sen UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06885424 | A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products(DESCENT-1) | enrolling by invitation | — | 400 | A2 Biotherapeutics Inc.INDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT07253298 | The Effects of Kegel Exercise Combined With Biofeedback Therapy on Bowel Function Recovery, Emotional Distress, and Quality of Life in Patients Following Low Anterior Resection for Rectal Cancer(BFT in LARS) | enrolling by invitation | N/A | 66 | National Taiwan University HospitalOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT06085560 | Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening | enrolling by invitation | N/A | 600 | Michigan State UniversityOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07576049 | COLORECTAL CANCER: SINGLE CENTER EXPERIENCE(CRC URomLS) | enrolling by invitation | — | 37 | University of Roma La SapienzaOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT06862479 | Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)(ES-LCCE-UDFM) | enrolling by invitation | — | 180 | Unidade Local de Saúde Santa MariaOTHER_GOV | 1 | May 6, 2026 | clinicaltrials |
| NCT07567716 | Infiltration Pattern of Locally Advanced ESCC | enrolling by invitation | — | 30 | Shanghai Chest HospitalOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07116668 | SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study(SAFE-3CV) | enrolling by invitation | N/A | 108 | SafeHeal IncINDUSTRY | 4 | Apr 29, 2026 | clinicaltrials |
| NCT06434376 | MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis | enrolling by invitation | Early Phase 1 | 10 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT05102981 | Function and Quality of Life After Emergency vs Planned Creation of a Stoma(StomaFUNQ) | enrolling by invitation | — | 700 | Eva Haglind, MD, PhD, professorOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06381882 | The Role of the Human Microbiome in Patients After Pancreatic Resection.(MiPac) | enrolling by invitation | — | 200 | St. Antonius HospitalOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT07298577 | Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer(STOPHCC-GAAD) | enrolling by invitation | N/A | 2,100 | Siriraj HospitalOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07542262 | Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers(NIVO402025) | enrolling by invitation | Phase 2 | 128 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07488312 | Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer(LUCENT-GC-01) | enrolling by invitation | Phase 1 | 37 | Qilu Hospital of Shandong UniversityOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07537205 | The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol | enrolling by invitation | N/A | 92 | Fudan UniversityOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07533825 | Laparoscopic Staging for Stage III Gastric Cancer(CGCA202501) | enrolling by invitation | N/A | 968 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06133439 | Rural Indiana Screening for Colorectal Cancer(RISCC) | enrolling by invitation | N/A | 11 | Indiana UniversityOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06474091 | Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) | enrolling by invitation | — | 100 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07470658 | Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy | enrolling by invitation | — | 1,274 | National Taiwan University HospitalOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT00587314 | The Effect of Ablation Therapy on Barrett's Esophagus(ablation IN BE) | enrolling by invitation | — | 600 | Mayo ClinicOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT06191185 | IMProving Adherence to Colonoscopy Through Teams and Technology(IMPACTT) | enrolling by invitation | N/A | 2,000 | University of California, San FranciscoOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07444099 | Early Postoperative Intervention in Gastric Cancer Patients | enrolling by invitation | N/A | 264 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 2, 2026 | clinicaltrials |
Data updated 6 hours agoSource updated Sep 29, 2026source: clinicaltrials